Company Fundamentals\Company Profile
A Wright Investors' Service Research Report:
Syntopix Group Plc
440 Wheelers Farms Road
Milford, CT 06461 U.S.A.
COMPANY PROFILE
Figures in Pounds Sterling
Wright Quality Rating:LCNN Key Data
Syntopix Group plc is a research and development company, focusing on the Ticker:
discovery of topical antimicrobials products in the cosmetic consumer healthcare and SYGR
pharmaceutical markets. The principal activity of the Company is the research,
discovery and development of compounds for use in both medicinal and consumer 2010 Sales:
healthcare markets principally in the areas of acne, oral hygiene and hair care. As of
151,000
July 31, 2010, the Company's compounds included SYN0126, SYN0040, SYN1113 and
SYN0129. As of July 31, 2010, the Company had a library of over 3,000 compounds.
The wholly owned subsidiaries of the Company include Syntopix Limited and Syntopix Major Industry:
Services Limited. Drugs, Cosmetics & Health
Care
Stock Chart Officers
Non Executive Chairman
Tom Bannatyne Sub Industry:
Ethical Drug Manufacturers
Executive Director & Chief
Executive Country:
Dr. Stephen P. Jones United Kingdom
Chief Financial Officer & Currency:
Secretary Pounds Sterling
J. Darren Bamforth
Fiscal Year Ends:
July
Employees
16
Exchanges:
LON
Stock Price (8/5/2011): 4.25 p Share Type:
Recent stock performance